Metis Global Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Metis Global Partners's AMGN Position: Q2 2026 in Review
Metis Global Partners reduced its Amgen (AMGN) stake by 22% in Q2 2026, selling an estimated $1.63M and leaving 17,289 shares worth $6.26M. The position accounts for 0.14% of the portfolio, ranked #114.
Metis Global Partners first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.19M in Q1 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Metis Global Partners held 17,289 shares of Amgen worth $6.26M as of Q2 2026.
- Metis Global Partners sold 4,763 Amgen shares in Q2 2026, an estimated $1.63M.
- Amgen made up 0.14% of Metis Global Partners's portfolio in Q2 2026, its #114 holding.
- Metis Global Partners first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Metis Global Partners's Amgen position peaked at $9.19M in Q1 2025.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.